Literature DB >> 3708815

Interlaboratory testing of the transferability of a candidate reference method for total cholesterol in serum.

G R Cooper, S J Smith, I W Duncan, A Mather, W D Fellows, T Foley, I D Frantz, J B Gill, T A Grooms, I Hynie.   

Abstract

In 1975 the Centers for Disease Control, in cooperation with the American Association for Clinical Chemistry Cholesterol Reference Method Study Group, began an investigation to develop a reference method for total cholesterol. Five potential reference methods were compared with the definitive method developed by the National Bureau of Standards before the chemical method of Abell et al. (J Biol Chem 1952;195:357-66) was selected as the recommended reference method. Because acceptance of a proposed reference method depends so greatly on the method's capability for transfer to other laboratories by written specifications and instructions, a transferability testing study was designed and conducted with 14 laboratories. The study consisted of preliminary testing of readiness of equipment, reagents, and personnel followed by transferability testing with eight runs on 10 serum pools. Laboratoires that did not meet readiness specifications had higher CVs in the transferability testing. The study demonstrated that the proposed method permits laboratories to attain a CV of less than 1.5% for one laboratory and of less than 3.0% among laboratories. The mean percent bias value was less than 1.0% for six of the 14 laboratories, less than 1.5% for 12, and less than 3.0% for all 14 laboratories.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3708815

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  1 in total

1.  Total cholesterol performance of Abell-Levy-Brodie-Kendall reference measurement procedure: Certification of Japanese in-vitro diagnostic assay manufacturers through CDC's Cholesterol Reference Method Laboratory Network.

Authors:  Masakazu Nakamura; Hiroyasu Iso; Akihiko Kitamura; Hironori Imano; Masahiko Kiyama; Shinji Yokoyama; Yuzo Kayamori; Isao Koyama; Kunihiro Nishimura; Michikazu Nakai; Mahnaz Dasti; Hubert W Vesper; Tamio Teramoto; Yoshihiro Miyamoto
Journal:  Clin Chim Acta       Date:  2015-03-26       Impact factor: 3.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.